Pharmacokinetics of mitomycin C in patients after bolus injection and chemobolisation of the hepatic artery with Spherex starch particles.

Abstract

The pharmacokinetics of mitomycin C after chemobolisation of the common hepatic artery by micronized Spherex starch particles (mean particle size 30 microns) were investigated in 5 cancer patients. Bolus injection and simultaneous occlusion of the artery lead to a significantly lower systemic circulation of mitomycin C in the blood vessel system than after bolus injection without chemobolisation. The plasma concentration-time curves showed lower values in the alpha-phase in the presence of Spherex (co = 743 ng/ml) than without starch particles (co = 987 ng/ml). Accordingly, the AUC values were significantly lower too (AUC = 28.6 micrograms/ml.h with Spherex and 39.7 micrograms/ml.h without Spherex), thus leading to a lower systemic bioavailability of the drug and a higher local bioavailability in the tumor region. Elimination of mitomycin from the central compartment was similar for both administrations (t1/2 = 27 min with Spherex and 28 min without Spherex) and showed the characteristic profile of the substance. The clinical picture showed a milder toxicity with a certain loss of side effects. These results indicate a significant and desirable change in the pharmacokinetics of mitomycin C during the distribution phase into the tissue of patients.

• Authors: M J Czejka, W Jäger, J Schüller
• Journal: European journal of drug metabolism and pharmacokinetics (Eur J Drug Metab Pharmacokinet) 1992 Apr-Jun Vol. 17 Issue 2 Pg. 85-7 ISSN: 0378-7966 [Print] France
• PMID: 1425815 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Mitomycin
• Spherex
• Starch

Topics

• Aged
• Embolization, Therapeutic
• Hepatic Artery
• Humans
• Liver Neoplasms (drug therapy, metabolism)
• Middle Aged
• Mitomycin (administration & dosage, pharmacokinetics)
• Starch (administration & dosage)